Ye Xu

440 total citations
11 papers, 224 citations indexed

About

Ye Xu is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Ye Xu has authored 11 papers receiving a total of 224 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Hematology and 3 papers in Cancer Research. Recurrent topics in Ye Xu's work include Acute Myeloid Leukemia Research (3 papers), Histone Deacetylase Inhibitors Research (3 papers) and Epigenetics and DNA Methylation (2 papers). Ye Xu is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Histone Deacetylase Inhibitors Research (3 papers) and Epigenetics and DNA Methylation (2 papers). Ye Xu collaborates with scholars based in United States and China. Ye Xu's co-authors include Liyong Huang, Guoxiang Cai, Sanjun Cai, Concepción Martínez, Stephen D. Nimer, Sarah Greenblatt, Jun Sun, Na Man, Daniel Karl and Fan Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Ye Xu

10 papers receiving 223 citations

Peers

Ye Xu

MB

CR

ONCOL

HEMAT

IMMUN

Sophia A. Wild United States

Roberto Ciaccio Italy

Wan-Ying Hsieh United States

Dong‐In Koh South Korea

Aimee T. Farria United States

Pavana Anur United States

Katie Holmes United States

Peter J. Mullen Canada

Nadine Haetscher Germany

Frédéric Canal France

Sophia A. Wild United States

Ye Xu

151 ×0.8

MB

89 ×1.4

CR

27 ×1.0

ONCOL

13 ×0.6

HEMAT

11 ×0.7

IMMUN

Citations per year, relative to Ye Xu Ye Xu (= 1×) peers Sophia A. Wild

Countries citing papers authored by Ye Xu

Since Specialization

Citations

This map shows the geographic impact of Ye Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Xu more than expected).

Fields of papers citing papers by Ye Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ye Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Xu. The network helps show where Ye Xu may publish in the future.

Co-authorship network of co-authors of Ye Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Ye Xu. A scholar is included among the top collaborators of Ye Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ye Xu. Ye Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Zheng, Wei, Zongsheng Zhao, Guang Li, et al.. (2025). Establishment and Validation of a Method for the Identification of Recessive Mastitis Resistance Genes in Dairy Cows. Genes. 16(5). 485–485.

2.

Xu, Ye, et al.. (2022). LOC100130075 Promotes Cervical Cancer Progression by Activating MDM2 Transcription through E2F1. Reproductive Sciences. 29(5). 1439–1448. 2 indexed citations

3.

Sun, Jun, Gabriel Gaidosh, Ye Xu, et al.. (2021). RAC1 plays an essential role in estrogen receptor alpha function in breast cancer cells. Oncogene. 40(40). 5950–5962. 11 indexed citations

4.

Li, Xin, Ye Xu, Weikang Guo, et al.. (2021). Acetylation-stabilized chloride intracellular channel 1 exerts a tumor-promoting effect on cervical cancer cells by activating NF-κB. Cellular Oncology. 44(3). 557–568. 16 indexed citations

5.

Xiong, Kun, et al.. (2020). Circular RNA circKIF4A Sponges miR-375/1231 to Promote Bladder Cancer Progression by Upregulating NOTCH2 Expression. Frontiers in Pharmacology. 11. 605–605. 29 indexed citations

6.

Liu, Fan, Ye Xu, Xiaoqing Lu, et al.. (2020). PRMT5-mediated histone arginine methylation antagonizes transcriptional repression by polycomb complex PRC2. Nucleic Acids Research. 48(6). 2956–2968. 45 indexed citations

7.

Xu, Ye, Na Man, Daniel Karl, et al.. (2019). TAF1 plays a critical role in AML1-ETO driven leukemogenesis. Nature Communications. 10(1). 4925–4925. 34 indexed citations

8.

Man, Na, Glòria Mas Martín, Daniel Karl, et al.. (2019). EP300 Suppresses Leukemia Development in Myelodysplastic Syndrome through Myb Repression. Blood. 134(Supplement_1). 561–561. 1 indexed citations

9.

Blumenthal, Ezra, et al.. (2017). Covalent Modifications of RUNX Proteins: Structure Affects Function. Advances in experimental medicine and biology. 962. 33–44. 11 indexed citations

10.

Huber, Ferdinand, Sarah Greenblatt, Andrew M. Davenport, et al.. (2017). Histone-binding of DPF2 mediates its repressive role in myeloid differentiation. Proceedings of the National Academy of Sciences. 114(23). 6016–6021. 27 indexed citations

11.

Huang, Liyong, et al.. (2011). Downregulation of S100A4 expression by RNA interference suppresses cell growth and invasion in human colorectal cancer cells. Oncology Reports. 27(4). 917–922. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact